{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-001026","form_type":"8-K","ticker":"ELOX","cik":"0001035354","company_name":"Eloxx Pharmaceuticals, Inc.","filed_at":"2022-01-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.184778+00:00","generated_at":"2026-06-27T20:27:40.468123+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Eloxx receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period until July 5, 2022","bullets":["Closing bid price of common stock below $1.00 for 30 consecutive business days as of Jan 3, 2022.","Company has until July 5, 2022 to regain compliance; may qualify for an additional 180-day grace period.","Options to cure include a reverse stock split; no assurance of regaining compliance.","Stock continues trading on Nasdaq Global Market under symbol ELOX during the cure period."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-001026","json":"https://secwatch.observer/filing/0001104659-22-001026.json","markdown":"https://secwatch.observer/filing/0001104659-22-001026.md","text":"https://secwatch.observer/filing/0001104659-22-001026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1035354/000110465922001026/0001104659-22-001026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1035354/000110465922001026/tm221588d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T20:27:40.468123+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}